{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T22:48:12Z","timestamp":1769554092879,"version":"3.49.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Hidradenitis suppurativa (HS) is a chronic, often debilitating skin condition that disproportionately impacts women in the United States and other Western nations. Dermatologists should consider incorporating palliative care principles into HS management to optimize care. Primary palliative care principles include utilizing evidence-based frameworks in serious illness communication, acknowledging and addressing physical and psychosocial suffering, recognizing and validating the burden of disease in partners, families, and caregivers, and engaging in collaborative care coordination. Certain patients may also benefit from outpatient, or sometimes inpatient, palliative care specialist collaboration, such as those with refractory HS and superimposed challenging psychosocial dynamics and symptom burden. Through integration of these palliative care domains into HS care, dermatologists can optimize their ability to provide comprehensive and compassionate care for patients suffering with this disease.<\/jats:p>","DOI":"10.1097\/jw9.0000000000000063","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T13:02:02Z","timestamp":1671195722000},"page":"e063","source":"Crossref","is-referenced-by-count":1,"title":["Integrating primary palliative care into hidradenitis suppurativa management"],"prefix":"10.1097","volume":"8","author":[{"given":"Terri","family":"Shih","sequence":"first","affiliation":[{"name":"David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Zell","sequence":"additional","affiliation":[{"name":"Palliative Care Program, Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Karlin","sequence":"additional","affiliation":[{"name":"Palliative Care Program, Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devea R.","family":"De","sequence":"additional","affiliation":[{"name":"University at Buffalo, Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Smogorzewski","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Harbor-UCLA Medical Center, Torrance, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian Y.","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock, Arkansas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Hsiao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Southern California, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,12,16]]},"reference":[{"key":"R1-20231102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-020-0149-1","article-title":"Hidradenitis suppurativa.","volume":"6","author":"Sabat","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20231102","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra1404684","article-title":"Palliative care for the seriously ill.","volume":"373","author":"Kelley","year":"2015","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"R3-20231102","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1046\/j.1525-1497.1999.00263.x","article-title":"Time and the patient-physician relationship.","volume":"14","author":"Dugdale","year":"1999","journal-title":"J Gen Intern Med"},{"key":"R5-20231102","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/bjd.19344","article-title":"Validation of global item for assessing impact on quality of life of patients with hidradenitis suppurativa.","volume":"184","author":"Kirby","year":"2021","journal-title":"Br J Dermatol"},{"key":"R6-20231102","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jaad.2020.09.039","article-title":"Pain management in hidradenitis suppurativa and a proposed treatment algorithm.","volume":"85","author":"Savage","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"R7-20231102","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.jaad.2020.05.090","article-title":"New-onset depression among children, adolescents, and adults with hidradenitis suppurativa.","volume":"83","author":"Wright","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R8-20231102","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1089\/jpm.2018.0207","article-title":"Top ten tips palliative care clinicians should know about mental health and serious illness.","volume":"21","author":"Riordan","year":"2018","journal-title":"J Palliat Med"},{"key":"R9-20231102","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaad.2021.01.059","article-title":"Comorbidity screening in hidradenitis suppurativa: evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.","volume":"86","author":"Garg","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"R10-20231102","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jaad.2019.09.023","article-title":"Support group utilization and impact for patients with hidradenitis suppurativa.","volume":"83","author":"Butt","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R11-20231102","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaad.2019.06.1301","article-title":"Evaluating patients\u2019 unmet needs in hidradenitis suppurativa: results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project.","volume":"82","author":"Garg","year":"2020","journal-title":"J Am Acad Dermatol"}],"container-title":["International Journal of Women\u2019s Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JW9.0000000000000063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T18:25:37Z","timestamp":1698949537000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JW9.0000000000000063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":10,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/jw9.0000000000000063","relation":{},"ISSN":["2352-6475"],"issn-type":[{"value":"2352-6475","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}